Showing information for - 'C14-carnitine'


Metabolite information

HMDB ID -
Synonyms
-
Chemical formula -
IUPAC name
-
CAS registry number -
Monisotopic molecular weight -

Chemical taxonomy

Super class -
Class -
Sub class -

Biological properties

Pahtways
-
Author-emphasized biomarker in the paper(s)

Lung cancer metabolomics studies that identify - 'C14-carnitine'


Reference Country Specimen Marker function Participants (Case) Participants (Control)
Cancer type Stage Number Gender (M,F) Age mean (range) (M/F) Smoking status Type Number Gender (M,F) Age mean (range) (M/F) Smoking status
Ni et al. 2019 serum diagnosis lung cancer 40 26, 14 66.7 (49-83) healthy 100 65, 35 64.1 (41-90)
Ni et al. 2019 serum diagnosis NSCLC, SCLC II, III, IV 17 13, 4 66.3 (53-77) former, current, non-smoker healthy 30 23, 7 62.8 (34-85) former, current, non-smoker
Reference Chromatography Ion source Positive/Negative mode Mass analyzer Identification level
Ni et al. 2019 LC ESI positive triple quadrupole MS/MS
Ni et al. 2019 LC ESI positive triple quadrupole MS/MS
Reference Data processing software Database search
Ni et al. 2019 HMDB, KEGG, SMPDB
Ni et al. 2019 HMDB, KEGG, SMPDB
Reference Difference method Mean concentration (case) Mean concentration (control) Fold change (case/control) P-value FDR VIP
Ni et al. 2019 Mann-Whitney U test, Student's t-test, Welch's F test 0.04 0.02 <0.001
Ni et al. 2019 Mann-Whitney U test, Student's t-test, Welch's F test 0.03 0.02 0.805
Reference Classification method Cutoff value AUROC 95%CI Sensitivity (%) Specificity (%) Accuracy (%)
Ni et al. 2019 ROC analysis 0.761
Ni et al. 2019 ROC analysis 0.52